Peripheral Arterial Disease in the Elderly


Study

N

Age range

Procedure/Outcome

Group 1

Group 2

P Value

Saarinen (2015) [34]

233

92* (90–100)

Surgical vs. Endovascular

Surgical

Endovascular
 
1-year survival

50.9%

48.6%

0.505

Limb salvage

85.1%

87.9%

0.259

Amputation-free survival

45.7%

44.4%

0.309

Chang (2001) [35]

383

70–79

Bypass, Septuagenarian vs. Octogenarian

Septuagenarians

Octogenarians
 
209

80–89

5-year survival

64%

54%

>0.2

5-year primary patency

68%

74%

>0.2

5-year limb salvage

86%

86%

NS

Brosi (2007) [37]

167

85.4** (80–94.9)

Surgical or endovascular vs. medical,

Octogenarians

Nonoctogenarians
 
249

69.3** (40.3–79.9)

Octogenarians vs. Nonoctogenarians
    
Primary clinical success

26.6%

31.2%

NS

Secondary clinical success

50.6%

55.0%

NS

Major amputation

22.3%

23.6%

NS

Repeated revascularization

48.3%

40.4%

NS

Masaki (2014) [33]

131

BY 70* (46–89)

Bypass vs. Endovascular

Bypass

Endovascular
 
33

EV 72* (47–89)

3-year primary patency

72%

54%

<0.009
 
3-year secondary patency

82%

60%

NR

3-year limb salvage

86%

82%

NS

Adam (2005) [32]

BY 228

EV 224

Bypass vs. Endovascular

Unadjusted

Adjusted
 
<70 35%

<70 30%

6-month amputation free survival

1.07 (0.72–1.6)

1.04 (0.69–1.56)

NS

70–79 39%

70–79 46%

Entire follow-up amputation-free survival

0.89 (0.68–1.17)

0.88 (0.66–1.16)

NS

≥80 26%

≥80 26%

Entire follow-up all-cause mortality

0.90 (0.66–1.22)

0.95 (0.69–1.29)

NS

Simons (2012) [47]

2110

CLI 69.9* ± 11.4

Bypass, CLI vs. Claudication

CLI

Claudication
 
797

IC 64.3* ± 10.4

1-year major amputation

12.2%

1.6%

<0.0001
 
1-year primary patency

66.4%

78.9%

<0.0001

1-year secondary patency

77.4%

89%

<0.0001


Abbreviations: CLI critical limb ischemia, NS not significant, NR not reported

*Median; **Mean; HR (95% CI) of surgery relative to angioplasty



In a recent study of nonagenarians referred for CLI or acute limb ischemia, 83% were living independently prior to surgery , with 72% remaining independent afterwards [34]. Eighty-two percent of the 91% that were ambulatory preoperatively maintained this status postoperatively. Both preoperative living status and ambulatory ability were no different between endovascular and open approaches. Dementia was the single and poor predictor of poor amputation-free survival in this cohort. In a study of septuagenarians and octogenarians with lower extremity CLI undergoing bypass procedures, 5-year survival was 54% and 64%, primary patency 74% and 68%, and limb salvage rate 86% in both age groups [35]. The authors suggest that these age groups stand to benefit from revascularization as a means to relieve symptoms and avoid the morbidity of amputation.

Improved stratification of PAD patients would assist clinical decision-making. To create a prediction score for the composite outcome of amputation and mortality at 1 year, researchers used data from the PREVENT III cohort (Project of Ex-Vivo graft Engineering via Transfection III) [36]. This dataset included 1404 patients with CLI who underwent infrainguinal bypass with autogenous vein. In this model, age greater than or equal to 75 years was an independent predictor of amputation and death in multivariable analysis and given two points in the risk score (HR 1.64, 95% CI 1.21–2.22, p = 0.001). Age alone was associated with an amputation-free survival of 89.7%. These results were also confirmed in an observation study of octogenarians with CLI [37]. In this cohort, periprocedural mortality in octogenarians was much higher after surgical bypass as compared to endovascular. Those who did survive had similar outcomes at 1 year as compared to those under 80, suggesting that there may be a cohort of older patients who will benefit from intervention. Other risk scores have identified similar factors from large cohorts, unfortunately none have been prospectively validated on all-comers presenting with CLI [38, 39]. See Table 8.2 for a summary of available prediction scores .


Table 8.2
Prediction models for patients undergoing revascularization for critical limb ischemia













































 
Finnvasc [38]

Prevent III [36]

BASIL [39]

CRAB [48]

Variables

One point each for:

Diabetes

CAD

Gangrene

Urgent operation

Dialysis = 4 points

Tissue loss = 3 points

Age ≥ 75 y = 2 points

Hematocrit <30 = 2 points

Advanced CAD = 1 point

Tissue loss

BMI

Creatinine

Bollinger score

Age

Smoking

History of MI or angina

Ankle pressure

Emergent case = 6 points

Total functional dependence = 6 points

Hemodialysis = 4 points

Recent angina/MI = 4 points

Age > 75 y = 3 points

Prior amputation/revascularization = 3 points

Ulceration = 3 points

Partial functional dependence = 3 points

Output

0–4 risk points

Low ≤ 3points

Medium = 4–7 points

High ≥ 8 points


Low = 0–6 points

Medium = 7–12 points

High > 12 points

Derivation Cohort

Finnvasc registry

PREVENT III cohort

BASIL trial

ACS-NSQIP 2007–2009

External Validation

Yes

Yes

No

No

Outcome

Major amputation and or death after infrainguinal revascularization for CLI

AFS after infrainguinal vein bypass for CLI

Death at 6, 12, and 24 months after LE bypass or angioplasty for CLI

Perioperative death or major morbidity after LE bypass for CLI


Adapted from Moxey et al. [49]

Abbreviations: AFS amputation free survival, CRAB comprehensive risk assessment for bypass, CLI critical limb ischemia, LE lower extremity, MI myocardial infarction, y years

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 18, 2017 | Posted by in CARDIOLOGY | Comments Off on Peripheral Arterial Disease in the Elderly

Full access? Get Clinical Tree

Get Clinical Tree app for offline access